ANDEXXA
Iraq – Federal (Baghdad) Opposition closed
Some details of this record were read from an image by OCR. Check them against the official bulletin.
| Notice | Application |
|---|---|
| Application no. | 81729 |
| Filing date | 10 Feb 2020 |
| Nice classes | 5 |
| Owner | Portola Pharmaceuticals, Inc |
| Address | 270 East Grand Avenue, South San Francisco, California 94080, United States of America |
| Country | United States |
| Bulletin | No. 1389, first announced 19 Jan 2021, page 159 |
| Opposition deadline | 19 Apr 2021 (90 days from the last announcement; confirm with the office) |
| Official source | Open the official bulletin (PDF) |